Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Developing Biomarkers for Fibromyalgia (Biomarkers)

This study has been completed.
Sponsor:
Collaborators:
The Dana Foundation
United States Department of Defense
Information provided by (Responsible Party):
Richard Harris, University of Michigan
ClinicalTrials.gov Identifier:
NCT00932061
First received: June 25, 2009
Last updated: July 18, 2013
Last verified: July 2013